Fertility-Sparing Approach For A Young Patient In Ovarian Cancer: Long-Term Follow-Up Of Ovarian Masses Against, Administration And Review Of The Literature

Yıl 2015, Cilt: 12 Sayı: 3, 130 - 132, 01.05.2015

Kadir Çetinkaya Ahmet Bacınoğlu Haluk Dervişoğlu

Öz

In the majority of young adult patients, long-term life expectancy is high with the current treatment of cancer. Although usually 5-year survival success criteria used in the follow-up of cancer, it is also possible as long as decades of survival. The level of implementation of the standard radical oncological treatment in young patients with early-stage ovarian cancer eliminates fertility. In spite of satisfactory oncological results, if patients are unable to establish her family, in terms of quality of life can be miserable. In this regard, fertility protective oncological surgery is remarkable with promising reproductive results. In this paper, early-stage 20 years old ovarian cancer patient who has been treated by fertility sparing surgery and over 10 years follow-up results are discussed in the view of literature.

Anahtar Kelimeler

Ovarian carcinoma, fertility sparing, surgery, treatment

Genç Bir Hastada Over Kanseri İçin Doğurganlık Koruyucu Yaklaşım: Uzun Dönemli Takipte Karşı Overde Kitle, Yönetimi ve Literatürün Gözden Geçirilmesi

Öz

Kanserin güncel tedavisi sayesinde genç yetişkin hastaların büyük çoğunluğunda uzun süreli yaşam beklentisi yüksektir. Her ne kadar kanser tedavisinde 5 yıllık sağ kalım başarı ölçütleri kullanılsa da, 10 yıllar boyu sağ kalım da mümkündür. Erken evre over kanserli genç hastada onkolojik tedavinin standart radikal düzeyde uygulanması doğurganlığı ortadan kaldırmaktadır. Ailesini kuramayan hasta ise onkolojik açıdan yüz güldürücü sonuçlar alınsa da, yaşam kalitesi anlamında mutsuz olabilmektedir. Bu bakımdan doğurganlık koruyucu onkolojik cerrahi, umut verici üreme sonuçları ile dikkat çekicidir. Bu yazıda 20 yaşında doğurganlığını koruyarak tedavi ettiğimiz erken evre over kanserli hastanın 10 yıl üzerinde takip sonuçları literatür eşliğinde tartışılmıştır.

Anahtar Kelimeler

Over kanseri, doğurganlık koruyucu, cerrahi, tedavi

Kaynakça

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.
• Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ: Survival effect of maximal cytoreductive surgery for advanced ovarian carcino- ma during the platinum era: a meta-analysis. J Clin Oncol 2002; 20: 1248–1259.
• Shih KK, Chi DS: Maximal cytoreductive effort in epithelial ovarian cancer surgery. J Gynecol Oncol 2010; 21: 75–80.
• Fleischer RT, Vollenhoven BJ, Weston GC. The effects of chemotherapy and radiotherapy on fertility in premenopausal women. Obstet Gynecol Surv 2011; 66:248-254.
• Green JA: Early ovarian cancer – time for a rethink on stage? Gynecol Oncol 2003; 90:235–237.
• Duska LR, Chang YC, Flynn CE, Chen AH, Goodman A, Fuller AF, Nikrui N: Epithelial ovarian carcinoma in the reproductive age group. Cancer 1999; 85: 2623–2629.
• Plaxe SC, Braly PS, Freddo JL, McClay E, Kirmani S, Howell SB: Profiles of women aged 30–39 and aged less than 30 with epithelial ovarian can- cer. Obstet Gynecol 1993; 81: 651–654.
• Di Saia PJ: Fertility-sparing treatment of patients with ovarian cancer. Compr Ther 1990; 16: 35–42.
• Rasool N, Rose PG: Fertility-preserving surgical procedures for patients with gynecologic malignancies. Clin Obstet Gynecol 2010; 53:804–814.
• Seli E, Tangir J: Fertility preservation options for female patients with malignancies. Curr Opin Obstet Gynecol 2005; 17: 299–308.
• Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Pecorelli S, Beller U. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006; 95 1:161-92.
• Eskander RN, Randall LM, Berman ML, Tewari KS, Disaia PJ, Bristow RE. Fertility preserving options in patients with gynecologic malignancies. Am J Obstet Gynecol. 2011; 205:103-10.
• Colombo N, Peiretti M, Parma G, Lapresa M, Mancari R, Carinelli S, Ses- sa C, Castiglione M; ESMO Guidelines Working Group. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guide- lines for diagnosis, treatment and follow-up. Ann Oncol 2010; 5:23-30.
• Fruscio R, Corso S, Ceppi L, Garavaglia D, Garbi A, Floriani I, Franchi D, Cantù MG, Bonazzi CM, Milani R, Mangioni C, Colombo N. Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series. Ann Oncol 2013; 24:138-44.
• Satoh T, Hatae M, Watanabe Y, Yaegashi N, Ishiko O, Kodama S, Yama- guchi S, Ochiai K, Takano M, Yokota H, Kawakami Y, Nishimura S, Ogis- hima D, Nakagawa S, Kobayashi H, Shiozawa T, Nakanishi T, Kamura T, Konishi I, Yoshikawa H. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol 2010; 28:1727-32.
• Borgfeldt C, Iosif C, Masback A: Fertilitysparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2007; 134: 110–114.
• Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH: Outcomes of fertilitysparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol 2008; 110: 345–353.
• Morice P, Uzan C, Gouy S, Pautier P, Lhomme C, Duvillard P: Results of conservative treatment of epithelial ovarian tumor. Gynecol Oncol 2009; 112: 673–674.
• Kajiyama H, Shibata K, Mizuno M, Umezu T, Suzuki S, Nawa A, Kawai M, Nagasaka T, Kikkawa F: Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those un- dergoing radical surgery. Br J Cancer 2011; 105: 1288–1294.
• Morice P, Wicart-Poque F, Rey A, El-Hassan J, Pautier P, Lhommé C, de Crevosier R, Haie-Meder C, Duvillard P, Castaigne D. Results of conser- vative treatment in epithelial ovarian carcinoma. Cancer 2001; 92:2412- 8.
• Petrillo M. Legge F, Ferrandina G, Monterisi A, Pedone Anchora L, Scam- bia G. Fertility-sparing surgery in ovarian cancer extended beyond the ovaries a case report and review of the literature. Gynecol Obstet Invest 2014; 77:1-5.
• Nam JH, Park JY. Fertility-Sparing Surgery for Young Women with Ear- ly-Stage Epithelial Ovarian Cancer. Gynecol Obstet Invest 2013; 76: 14- 24.
• Schilder JM, Thompson AM, DePriest PD, Ueland FR, Cibull ML, Kryscio RJ, Modesitt SC, Lu KH, Geisler JP, Higgins RV, Magtibay PM, Cohn DE, Powell MA, Chu C, Stehman FB, van Nagell J: Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 2002; 87: 1–7.
• Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH: Outcomes of fertilitysparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol 2008; 110: 345–353.
• Schlaerth AC, Chi DS, Poynor EA, Barakat RR, Brown CL: Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. Int J Gynecol Cancer 2009; 19: 1199–1204.
• Kajiyama H, Shibata K, Suzuki S, Ino K, Nawa A, Kawai M, Nagasaka T, Kikkawa F: Fertility-sparing surgery in young women with invasive epit- helial ovarian cancer. Eur J Surg Oncol 2010; 36: 404–408.
• McGuire V, Jesser CA, Whittemore AS: Survival among US Women with invasive epithelial ovarian cancer. Gynecol Oncol 2002; 84:399–403.
• Schueler JA: Early ovarian carcinoma surgical staging and prognostic factors. Eur J Obstet Gynecol Reprod Biol 1999; 85: 127–129.
• Benjamin I, Morgan MA, Rubin SC. Occult bilateral involvement in stage I epithelial ovarian cancer. Gynecol Oncol 1999; 72:288–291.
• Ortaç F, Kahraman K. Jinekolojik Onkolojide Fertilite Koruyucu Cerrahiler. Turkiye Klinikleri J Gynecol Obst-Special Topics 2012; 5:47-56.